MedPath

Bacterial growth and susceptibility pattern of antibiotics in Subglottic versus Endotracheal Secretion in patients with Ventilator-associated Pneumonia

Not Applicable
Conditions
Health Condition 1: J189- Pneumonia, unspecified organism
Registration Number
CTRI/2022/08/044892
Lead Sponsor
one
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Age >18 years of age, invasive mechanical ventilation for at least 48 hours and new onset Clinically defined VAP

Exclusion Criteria

1.Pre-existing Healthcare associated pneumonia within last 90 days

2.Community acquired pneumonia

3.Pregnancy

4.Organ transplant

5.Any immunocompromised state

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To estimate the diagnostic accuracy of antibiotic-sensitivity profile of bacterial isolates identified within SGA culture versus convergent ETA culture isolates in patients with clinically defined VAP undergoing IMVTimepoint: At onset of clinical VAP
Secondary Outcome Measures
NameTimeMethod
To analyse the clinical outcome parameters with respect to culture sensitivity report.Timepoint: 28 days post inclusion, discharge or death whichever occurs earlier;To identify convergence and accuracy within microbiological flora of ETA versus SGA sample of patients undergoing IMV with clinically defined VAP.Timepoint: At onset of clinical VAP
© Copyright 2025. All Rights Reserved by MedPath